BOYANOV & Co. provided legal support to BioIVT, a leading provider of biospecimens, research models, and drug and diagnostic development services, for the successful acquisition of Fidelis Research, an 85-site clinical biospecimen collection network in Southeastern Europe with headquarters in Sofia, Bulgaria.
The transaction increased the scale and depth of BioIVT’s global operations by adding new clinical collection sites, predominantly hospital-based, focused on oncology, heme-oncology, and autoimmune cases. Special attention was paid to the preservation and further development of the relations with the leading members of the Fidelis staff.
The team was led by our partner Yordan Naydenov and included Svetlina Kortenska (senior counsel), Mihail Vishanin (counsel), and Nedyalka Novakova (senior associate).